
Cardiovascular


Optimising Heart Failure GDMT with the Rapid Titration (RaT) Pathway comprising several hospitals in Northland

Reducing Mortality and Readmission with HF Multidisciplinary Model of Care

Implementing 0/1-Hour Algorithm using High-Sensitivity Cardiac Troponin in the Emergency Department



Every Heartbeat Counts: Take Action & Make an Impact This World Heart Day


EMPORIUM – Full Throttle Against HF: From Detection to Protection



Every Heartbeat Counts: Take Action & Make an Impact This World Heart Day


Value of biomarker in HFpEF Diagnosis


Sex-specific Differences in Heart Failure


STRONG-HF: Enhancing GDMT regimen in Asia


Heart Failure Care Beyond City Limits: Insights from a Cardiologist


Implementation of STRONG-HF protocol in heart failure management: an Australian perspective


Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China


When every minute counts: A deep dive into IJN Malaysia’s quest for rapid triage for chest pain patients in the ED


Reshaping HF Management at NHCS


Quantum leap in reducing rehospitalization in HF by 70-80% – How and where?


2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery


STRONG-HF: Rapid Uptitration of Guideline Directed Medical Therapy for Heart Failure


Guidelines Interpretation – Guidelines for the management of chronic heart failure in dialysis patients in China


Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment



Download APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment Monitoring


Perioperative myocardial injury (PMI) management: Challenges and feasibility of active screening in non-cardiac surgeries


Heart Failure Management in India – Overcoming Present Challenges


STRONG-HF study highlighting benefits of treatment optimisation


STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy


NT-proBNP and ECHO in heart failure – do they always go hand in hand?


Rapid ACS Rule Out in Emergency Patients


How to Implement the 0-h/1-h Algorithm to your Institute?


High Sensitivity Cardiac Troponins and ACS – the Malaysian Experience


APAC Heart Failure Gap Report


Rational use of troponin and optimal management of cardiovascular diseases


Value of NT-ProBNP for Treatment Monitoring in CHF


The evidence for 0/1-hour algorithm for Asia? DROP-Asian ACS Study


Process Optimization for Emergency hs-TnT Detection


Clinical Application Value of NT-proBNP in Chronic Kidney Diseases Patients with Cardiovascular Diseases


High Sensitivity Troponin vs Conventional Troponin: An Expert View


The rationale for the use of hs-cTn in the optimal management of ACS


Rapid algorithms for hs-cTn in ED: Boon or Bane?


ESC 2021 Heart Failure Guidelines: What’s new?


Heart Failure in Hong Kong- Present Challenges and Future Strategies



Tips for implementing ESC high sensitivity cardiac troponin (hs-cTn) rapid algorithms for triage of AMI patients


Rapid Algorithms for Faster Triage of ED Patients with Suspected AMI – What Are We Waiting For?



Comparing the ESC high sensitivity cardiac troponin (hs-cTn) rapid algorithms for triage of AMI patients



STROKESTOP II Study: Precision risk screening for atrial fibrillation in elderly



Atrial Fibrillation in Elderly: Screening tools and role of NT-proBNP


Advantages of early NT-proBNP testing in patients suspected with heart failure


What is the Peptide for Life initiative?


Digital Prediction Platforms: A catalyst towards personalized CVD prognosis



Heart Failure in Asia – Present Challenges and Future Strategies


Perioperative Myocardial Infarction in Non-Cardiac Surgery – Why Measuring Troponin is Important?



Clinical Cases: Differentiating acute from chronic cardiac conditions



Clinical Cases: Diagnostic relevance of elevated hs-cTnT



Clinical Cases from Korea: Serial NT-proBNP measurement and Heart Failure prognosis



Clinical Cases from Korea: NT-proBNP for Differential diagnosis of patients with dyspnoea


Clinical Cases from Korea: Value of NT-proBNP in Cardiomyopathy


Clinical Cases from Korea: High NT-proBNP levels useful in differential diagnosis of HF


ESC Recommendation: High sensitivity troponin assay vs conventional assay


ESC Recommendation: Rapid algorithms using hs troponin in ED



Dr David Sim’s Clinical Cases: NT-proBNP in Heart Failure Patients








CANVAS study: NT-proBNP and CVD risk reduction


Clinical Cases: Elevations of hs-TnT in Non-cardiac Conditions


Clinical Cases: hs-TnT in Patients with End Stage Renal Failure


Clinical Cases: Serial Monitoring Differentiates Acute and Chronic hs-TnT Elevation



Dr Lee’s Clinical Cases: hs-TnT Chronic Elevation non-AMI cases



Dr Lee’s Clinical Cases: hs-TnT Early “Rule-In” for AMI


FAQ: NT-proBNP Interpretation in Multiple Scenarios


FAQ: NT-proBNP vs Cardiac Medications


FAQ: Role of NT-proBNP in Heart Failure Management


At the forefront of Acute Coronary Syndrome management in ED


What should we take note of when using hs-TnT for CKD patient?


Clinical Relevance of hs-Tn age specific cut-offs


Clinical Relevance of hs-TnT gender specific cut-offs


Recommended Steps to Implement 0h/1h Algorithm in Asia


Setting sight on breakthrough diagnostics


Benefits of 0h/1h Algorithm in a Thai Institution


Benefits of 0h/1h Algorithm to Patients in Asia


Recommendations of IFCC on Natriuretic Peptide Testing








How will NT-proBNP testing evolve in the future?



Is NT-proBNP validated for different population groups?








Reference ranges for NT-proBNP & hs-TnT in Asian populations


How to Implement ESC Rapid Algorithm Successfully?


The Changes in Rapid Algorithms for Acute Coronary Syndrome


Factors affecting high-sensitivity cardiac troponin (hs-cTn) levels


DAPA-HF and EMPEROR-Reduced Study Highlights


The role of biomarkers in HF


Digital health in HF management


Benefits of the 0h/1h algorithm in a Japanese institution



Serial testing of hs cTn rules out low risk of AMI


Patient Case Studies Using 0h/1h Algorithm


Latest IFCC Recommendations for Natriuretic Peptides in Heart Failure – Analytics and Clinical Considerations








BNP vs NT-proBNP: An Expert View


Natriuretic Peptide Measurement during ARNi Treatment








Impact of ARNi Therapy on Natriuretic Peptide Use


Summary of APSC High Sensitivity Troponin T Consensus


NT-proBNP in Hospital & Ambulatory Settings: Evidence to Clinical Practice



How to Use NT-proBNP for Prognosis and Monitoring?



What Should Hospitals Consider when Implementing Rapid Algorithm?



Early triage of patients with acute chest pain with hs-TnT 0h/1h Algorithm


TRAPID-AMI sub-study: Use of very low concentration of hs-TnT to rule out AMI using a single blood test



Benefits of hs-Tn 0h/1h Algorithm in ED & Hospital


TRAPID-AMI Study: hs-TnT for Rapid Rule In/ Out of AMI


Benefits of hs-Tn 0h/1h Algorithm to Chest Pain Patients


Management of Cardiovascular Risks of COVID-19 Patients








How NT-proBNP Made a Difference: Dr Januzzi’s Patient Story


Impact of hs-Tn on Further Cardiac Testing in Suspected AMI Patients


COVID-19 and the Heart, Experience from Front Line


Switching from Conventional to High-Sensitivity Troponin


How hs-TnT Made a Difference – Dr Twerenbold’s Story



How NT-proBNP Made a Difference: Dr Richards’ Patient Story








Natriuretic Peptides in the Latest ESC & AHA HF Guidelines



Role of Natriuretic Peptides in Patients with Dypsnea


Novel Biomarker-based Risk Score in AF: ABC Risk Score


Understanding Reasons for Increased Troponin Levels


hs-TnT Rapid Diagnosis of AMI- ESC 0h/3h Algorithm

